OBESITY

Metabolic and bariatric surgery in adolescents

A new study has added valuable outcome data from adolescents 5 years after undergoing Roux-en-Y gastric bypass. By comparing outcomes from adolescents and adults, the study adds to the existing evidence base, highlighting metabolic and bariatric surgery as an increasingly valuable tool in the multidisciplinary management of adolescents with severe obesity.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1

References

  1. 1.

    Pratt, J. S. A. et al. ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. Surg. Obes. Relat. Dis. 14, 882–901 (2018).

    Article  Google Scholar 

  2. 2.

    Inge, T. H. et al. Five-year outcomes of gastric bypass in adolescents as compared with adults. N. Engl. J. Med. 380, 2136–2145 (2019).

    Article  Google Scholar 

  3. 3.

    Olbers, T. et al. Laparoscopic roux-en-y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study. Lancet Diabetes Endocrinol. 5, (174–183 (2017).

    Google Scholar 

  4. 4.

    Inge, T. H. et al. Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis. Lancet Diabetes Endocrinol. 5, 165–173 (2017).

    Article  Google Scholar 

  5. 5.

    Group, T. S. et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N. Engl. J. Med. 366, 2247–2256 (2012).

    Article  Google Scholar 

  6. 6.

    Kahn, S. E. et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N. Engl. J. Med. 355, 2427–2443 (2006).

    CAS  Article  Google Scholar 

  7. 7.

    Beamish, A. J., D’Alessio, D. A. & Inge, T. H. Controversial issues: when the drugs don’t work, can surgery provide a different outcome for diabetic adolescents? Surg. Obes. Relat. Dis. 11, 946–948 (2015).

    Article  Google Scholar 

  8. 8.

    Sjostrom, L. et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 311, 2297–2304 (2014).

    Article  Google Scholar 

  9. 9.

    Mingrone, G. et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 386, 964–973 (2015).

    Article  Google Scholar 

  10. 10.

    Beamish, A. J. et al. Cardiovascular effects of bariatric surgery. Nat. Rev. Cardiol. 13, 730–743 (2016).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Torsten Olbers.

Ethics declarations

Competing interests

T.O. serves as consultant for Ethicon Endo surgery as participant in global advisory board and in lecturing, is a member of an advisory board for NovoNordisk and has also lectured for AstraZeneca, Merck, Mölnlycke and SanofiAventis; all revenue to institution. A.J.B. declares no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Beamish, A.J., Olbers, T. Metabolic and bariatric surgery in adolescents. Nat Rev Gastroenterol Hepatol 16, 585–587 (2019). https://doi.org/10.1038/s41575-019-0187-x

Download citation

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing